What GLP-1 drugs reveal about MPNs, inflammation, and cancer risk A surprising link between inflammation, clonal blood stem cells, and a blockbuster drug opens new

What do megakaryocytes, machine learning, and a team of Oxford scientists have in common? They’re all part of Dr. Daniel Royston’s mission to teach computers

Explaining a chronic cancer like an MPN to a child can feel overwhelming — especially when the symptoms aren’t always visible. In this new article,

At the center of translational research, clinical care, and academic leadership, Dr. Gabriela Hobbs, MD is charting a more thoughtful path forward for people living

MPN Pathways: Empowered Voices in Research bonus session — What’s your why? At MPN Research Foundation, we are dedicated to ensuring that the patient’s voice

Profile: Brandi Reeves, MDUniversity of North Caroline at Chapel Hill Hematologist discovers the kidneys: One researcher’s quest to explain an overlooked MPN complication   It all